09/26/2025
Dengue isn’t just a public health concern, it’s a national security risk.
In tropical regions, U.S. service members face real risk. One study found that 11% of Army Special Forces tested positive for dengue antibodies post-deployment. Even mild cases can take soldiers off the field. Severe cases? They can be mission-ending.
With limited treatment options and a vaccine approved only for select populations, the threat is real for both military readiness and public health.
That’s why researchers at Trudeau Institute are working to close the gap. Our scientists are advancing critical dengue research to help protect communities at home and troops abroad.